Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
BVS

Market Cap: $879.37M

BI

Bioventus Inc.

BVS

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin68.00%

EBITDA Margin15.95%

EBIT Margin10.06%

Pre-tax Margin6.64%

Net Profit Margin9.36%

Earnings Yield6.18%

Valuation Multiples

Price / Book3.86

Price / Sales1.51

Price / Earnings16.16

PEG0.00

Forward PEG0.88

EV / Sales1.91

EV / EBITDA12.00

EV / Operating Cash Flow11.50

EV / Free Cash Flow11.81

Price / Free Cash Flow9.33

Price / Operating Cash Flow9.09

Cash Flow & Capital

Free Cash Flow / Share$1.39

Operating Cash Flow / Share$1.43

Free Cash Flow Yield10.72%

Capex / Revenue0.44%

Capex / Operating Cash Flow2.67%

Capex / Depreciation0.06

Stock Compensation / Revenue2.56%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.69

Quick Ratio1.17

Cash Ratio0.19

Debt / Assets0.39

Debt / Capital0.54

Debt / Equity1.16

Long-Term Debt / Capital0.50

Debt / Market Cap28.72%

Net Debt / EBITDA2.52

Solvency Ratio0.22

Financial Leverage2.95

Efficiency & Working Capital

Asset Turnover0.86

Fixed Asset Turnover0.00

Inventory Turnover2.33

Receivables Turnover4.20

Payables Turnover9.22

Days Sales Outstanding86.82

Days Inventory Outstanding156.44

Days Payables Outstanding39.59

Operating Cycle243.26

Cash Conversion Cycle203.67

Working Capital Turnover5.63

Returns & Quality

Return on Equity28.39%

Return on Assets8.09%

Return on Invested Capital11.37%

ROCE11.87%

Return on Tangible Assets17.30%

Operating Return on Assets9.34%

Income Quality1.58

Tax Burden1.41

Interest Burden0.66

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.11B

Invested Capital$463.58M

Working Capital$105.08M

Tangible Asset Value$-81.1M

Net Current Asset Value$-138.41M

Graham Number$7.79

Graham Net-Net-$3.28

Book Value / Share$4.09

Tangible Book Value / Share-$1.19

Cash / Share$0.43

Financial Health Scores

Piotroski Score8

Altman Z-Score2.16

Revenue$581.85M

EBIT$58.52M

Market Cap$953.22M

Working Capital$105.08M

Retained Earnings$-298.38M

Total Assets$673.35M

Total Liabilities$395.93M